Is R(+)-Baclofen the best option for the future of Baclofen in alcohol dependence pharmacotherapy? Insights from the preclinical side.

Addiction Biology
Victor Echeverry-AlzateMickaël Naassila

Abstract

For several decades, studies conducted to evaluate the efficacy of RS(±)-Baclofen in the treatment of alcohol dependence yielded contrasting results. Human and animal studies recently questioned the use of the racemic drug in patients since a potential important role of the different enantiomers has been revealed with an efficacy thought to reside with the active R(+)-enantiomer. Here we conducted experiments in the postdependent rat model of alcohol dependence to compare the efficacy of R(+)-Baclofen or S(-)-Baclofen to that of RS(±)-Baclofen on ethanol intake, seeking, and relapse. R(+)-Baclofen was more effective than RS(±)-Baclofen in reducing ethanol intake and seeking during acute withdrawal and during relapse after abstinence. We also used an original population approach in order to identify drug responders. We found a significant proportion of responders to S(-)-Baclofen and RS(±)-Baclofen, displaying an increase in ethanol intake, and this increasing effect on alcohol intake was not seen in the R(+)-Baclofen group. At an intermediate dose of R(+)-Baclofen, devoid of any motor side effects, we identified a very large proportion of responders (75%) with a large decrease in ethanol intake (90% decrease). Finally, the resp...Continue Reading

References

Nov 1, 1978·European Journal of Pharmacology·H R OlpeH L Haas
Mar 1, 1990·Neuropharmacology·G H FrommC F Terrence
Jan 1, 1983·British Journal of Pharmacology·N G BoweryA L Hudson
Sep 10, 2002·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Liana FattoreWalter Fratta
Apr 2, 2003·Psychopharmacology·Giancarlo ColomboGian Luigi Gessa
Aug 11, 2004·Pharmacology, Biochemistry, and Behavior·Michael F Stromberg
Nov 10, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·M Herzog
Dec 15, 2004·Alcoholism, Clinical and Experimental Research·Barbara A FlanneryAmy Trivette
Apr 26, 2006·Alcoholism, Clinical and Experimental Research·Cristine L CzachowskiKirstie H Stansfield
Jan 9, 2007·Alcoholism, Clinical and Experimental Research·Brendan M Walker, George F Koob
Aug 2, 2008·Alcoholism, Clinical and Experimental Research·Jeffrey A SimmsSelena E Bartlett
Mar 6, 2010·CNS & Neurological Disorders Drug Targets·Lorenzo LeggioGiovanni Addolorato
Mar 25, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Emmanuelle Simon O'BrienMickaël Naassila
Sep 17, 2013·Alcoholism, Clinical and Experimental Research·Amélie MarsotNicolas Simon
May 16, 2014·JAMA : the Journal of the American Medical Association·Daniel E JonasJames C Garbutt
Jan 1, 2012·Metabolites·Raymundo Sanchez-PonceRoger Rush
Jul 22, 2014·Addiction Biology·Emmanuelle Simon-O'BrienCatherine Vilpoux
Aug 21, 2014·Addiction Biology·Stéphanie Alaux-CantinMickaël Naassila
Sep 24, 2014·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·K C MorleyP S Haber
Oct 25, 2014·European Addiction Research·Jürgen RehmGerhard Gmel
Nov 19, 2014·Addiction Biology·Marcus W Meinhardt, Wolfgang H Sommer
Jun 23, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Benjamin RollandOlivier Cottencin
Jul 25, 2015·Alcoholism, Clinical and Experimental Research·Bruce ImbertNicolas Simon
Mar 5, 2016·Trends in Pharmacological Sciences·Anton BespalovThomas Hudzik
May 6, 2016·Frontiers in Psychiatry·Irene LorraiGiancarlo Colombo
Aug 9, 2016·Pharmacology, Biochemistry, and Behavior·Brittany M PriddyLeandro F Vendruscolo
Nov 16, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Karl MannWim van den Brink
May 20, 2017·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Michel ReynaudMichel Detilleux
May 31, 2017·Addiction Biology·Sophie LebourgeoisCatherine Vilpoux
Nov 2, 2017·Fundamental & Clinical Pharmacology·Lucie ChevillardXavier Declèves

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.